000 01613 a2200457 4500
005 20250515154512.0
264 0 _c20100817
008 201008s 0 0 eng d
022 _a1532-866X
024 7 _a10.1016/j.semarthrit.2008.11.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMease, Philip J
245 0 0 _aLong-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
_h[electronic resource]
260 _bSeminars in arthritis and rheumatism
_cJun 2010
300 _a454-64 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAntidepressive Agents
_xtherapeutic use
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aDisability Evaluation
650 0 4 _aDouble-Blind Method
650 0 4 _aDuloxetine Hydrochloride
650 0 4 _aFemale
650 0 4 _aFibromyalgia
_xdrug therapy
650 0 4 _aHealth Status
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPain
_xdrug therapy
650 0 4 _aPain Measurement
650 0 4 _aThiophenes
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aRussell, I Jon
700 1 _aKajdasz, Daniel K
700 1 _aWiltse, Curtis G
700 1 _aDetke, Michael J
700 1 _aWohlreich, Madelaine M
700 1 _aWalker, Daniel J
700 1 _aChappell, Amy S
773 0 _tSeminars in arthritis and rheumatism
_gvol. 39
_gno. 6
_gp. 454-64
856 4 0 _uhttps://doi.org/10.1016/j.semarthrit.2008.11.001
_zAvailable from publisher's website
999 _c18600276
_d18600276